Dr Lacombe, Director EORTC Headquarters, talks with ecancer.tv about SPECTA during WIN 2014
8 Jul 2014
Dr Denis Lacombe, Director EORTC Headquarters, spoke with ecancer.tv about the EORTC’s SPECTA, Screening Patients for Efficient Clinical Trial Access, initiative during WIN 2014. He discussed the SPECTA initiative and perspectives for effective cancer drug development.
Watch here the video of the interview
Related News
World Cancer Day: How clinical cancer research changes lives
4 Feb 2026
New international study shows access to patient-reported outcome data improves the consistency of the evaluation of cancer treatment adverse events
27 Jan 2026
First Site Activated and First Patient Randomised in new brain cancer study VIGOR – EORTC‑2427‑BTG
26 Jan 2026
EORTC and EMA, jointly with international stakeholders, have published a multistakeholder roadmap to accelerate treatment optimisation in oncology
16 Jan 2026
New EORTC quality of life questionnaire for adolescents and young adults with cancer
8 Jan 2026
P-Value Workshop
19 Dec 2025
EORTC participation at ISPOR Europe 2025 conference
7 Nov 2025
EORTC Quality of Life Group participating at the ISOQOL 2025 Conference
22 Oct 2025
New results and forthcoming trials presented at ESMO 2025 underline EORTC’s commitment to patient-centred research
21 Oct 2025
EORTC celebrates the 100th anniversary of p-value on World Statistics Day
20 Oct 2025
